8-K: ModivCare Reports Mixed Q2 Results, Adjusts Full-Year EBITDA Guidance

ModivCare's second quarter results show consistent revenue year-over-year but a net loss, leading to a lowered adjusted EBITDA guidance for 2024.

Summary

• ModivCare reported second quarter 2024 service revenue of $698.3 million, which is consistent with the same period in 2023.
• The company experienced a net loss of $128.9 million, or negative $9.07 per diluted common share.
• Adjusted EBITDA for the quarter was $45.4 million, with an adjusted net loss of $0.4 million, or negative $0.03 per diluted common share.
• Cash used in operating activities was $55.3 million, and free cash flow was negative $62.0 million.
• ModivCare won $97.8 million in new Non-Emergency Medical Transportation (NEMT) contracts during the quarter.
• The company has lowered its 2024 adjusted EBITDA guidance to a range of $185 million to $195 million, down from the previous range of $190 million to $210 million.
• Revenue guidance for 2024 remains unchanged at $2.7 billion to $2.9 billion.
• A goodwill impairment of $105.3 million was recognized in the Remote Patient Monitoring (RPM) segment due to lower than expected membership and revenue.

Sentiment

Score: 4

Explanation: The document presents mixed results with some positives in NEMT but significant negatives including a net loss, lowered guidance, and a goodwill impairment. The overall sentiment is cautious and slightly negative.

Positives

• ModivCare's NEMT segment showed strong performance due to new business wins, upward repricing, and platform automation.
• The company successfully refinanced its 2025 senior unsecured notes, improving its capital structure.
• The company's personal care and remote patient monitoring segments have made significant progress.
• ModivCare's operating loss improved to $98.9 million from $175.8 million in the same quarter last year.
• Cash used in operations decreased to $55.3 million from $108.2 million in the second quarter of 2023.

Negatives

• ModivCare reported a net loss of $128.9 million for the quarter.
• Adjusted net loss was $0.4 million, compared to an adjusted net income of $20.8 million in the same quarter last year.
• Cash used in operating activities was $55.3 million.
• Free cash flow was negative $62.0 million.
• The company lowered its 2024 adjusted EBITDA guidance.
• The RPM segment experienced a $105.3 million goodwill impairment.
• The personal care services transformation has increased the company's cost structure and moderated growth in the first half of 2024.

Risks

• The company faces risks related to government or private insurance program funding reductions.
• There are risks associated with the implementation of alternative payment models.
• ModivCare is exposed to potential inadequacies or security breaches of its information technology systems.
• The company's contracts may not survive until the end of their stated terms or may not be renewed.
• There is a risk of not being awarded contracts through government requests for proposals.
• The company faces risks related to labor disputes and disruptions, particularly in New York.
• There are risks associated with operating in the competitive remote patient monitoring industry.
• The company's existing debt agreements contain restrictions and financial covenants that limit its flexibility.
• The company is dependent on its subsidiaries to fund its operations and expenses.

Future Outlook

ModivCare has maintained its revenue guidance for 2024 but lowered its adjusted EBITDA guidance. The company expects working capital to normalize in the second half of 2024 and is focused on de-levering its balance sheet, executing its transformation strategy, and optimizing business operations.

Management Comments

• Second quarter adjusted EBITDA of $45 million was driven by strong performance within our NEMT segment due to new business wins, upward repricing, and platform automation, stated L. Heath Sampson, President and CEO.
• We lowered our 2024 Adjusted EBITDA guidance range, primarily due to our personal care services transformation, which provides a solid foundation for growth, but it has also increased our cost structure and moderated growth in the first half of 2024.
• Our top priority is to de-lever our balance sheet while executing our transformation strategy, optimizing our business operations, and exploring other opportunities.

Industry Context

ModivCare operates in the healthcare services industry, providing non-emergency medical transportation, personal care services, and remote patient monitoring. The company's performance is influenced by factors such as government funding, reimbursement rates, and competition. The lowered EBITDA guidance and goodwill impairment suggest challenges in the personal care and remote patient monitoring segments, while the NEMT segment shows strength.

Comparison to Industry Standards

• ModivCare's revenue consistency year-over-year is a positive sign, but the net loss and lowered EBITDA guidance are concerning when compared to industry leaders in healthcare services.
• Companies like LogistiCare (now part of Carelon) and MTM, which are major players in the NEMT space, often report more stable financial results, suggesting ModivCare may be facing unique challenges.
• In the remote patient monitoring sector, companies like Teladoc Health and Livongo (now part of Teladoc) have shown stronger growth and profitability, indicating ModivCare's RPM segment is underperforming.
• The goodwill impairment in the RPM segment is a significant negative, suggesting the company overvalued this asset or is struggling to compete effectively in this market.
• The company's adjusted EBITDA margin of 6.5% is lower than some of its peers in the healthcare services sector, which often achieve margins in the 8-12% range.

Stakeholder Impact

• Shareholders may be concerned about the net loss and lowered EBITDA guidance.
• Employees may be affected by the company's restructuring and cost-cutting measures.
• Customers may experience changes in service delivery as the company transforms its personal care services.
• Suppliers may be impacted by changes in the company's financial performance.
• Creditors may be concerned about the company's increased working capital needs and debt levels.

Next Steps

• ModivCare will hold a conference call on August 8, 2024, to discuss the financial results.
• The company will focus on de-levering its balance sheet and executing its transformation strategy.
• ModivCare will continue to optimize its business operations and explore other opportunities.

Key Dates

Keywords

ModivCare, NEMT, Personal Care Services, Remote Patient Monitoring, Adjusted EBITDA, Financial Results, Healthcare Services, Goodwill Impairment, Guidance, Term Loan B